MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies
Business Announcement
Updates every hour. Last Updated: 14-Sep-2025 19:11 ET (14-Sep-2025 23:11 GMT/UTC)